Majado, Gloria P.
HRN: 06-60-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/25/2025
04/14/2025
IVTT
2.25
Every 6hrs
Sepsis Secondary To CAP-HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes